Does Hualan Biological Vaccine (SZSE:301207) Have A Healthy Balance Sheet?
Hualan Biological Vaccine's (SZSE:301207) Shareholders Have More To Worry About Than Only Soft Earnings
We Think Hualan Biological Vaccine (SZSE:301207) Can Manage Its Debt With Ease
Many Still Looking Away From Hualan Biological Vaccine Inc. (SZSE:301207)
Declining Stock and Decent Financials: Is The Market Wrong About Hualan Biological Vaccine Inc. (SZSE:301207)?
Hualan Biological Vaccine (SZSE:301207) Could Be A Buy For Its Upcoming Dividend
Hualan Biological Vaccine to Buy Back Up to 200 Million Yuan Worth of Shares
Hualan Biological Vaccine Chairman Proposes Up to 200 Million Yuan Buyback
Express News | Hualan Biological Vaccine Says It Will Adjust Prices for Four Influenza Vaccines From June 5, Expects Negative Impact on Revenues
Investors Aren't Entirely Convinced By Hualan Biological Vaccine Inc.'s (SZSE:301207) Earnings
Analyst Forecasts Just Became More Bearish On Hualan Biological Vaccine Inc. (SZSE:301207)
Should Weakness in Hualan Biological Vaccine Inc.'s (SZSE:301207) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
An Intrinsic Calculation For Hualan Biological Vaccine Inc. (SZSE:301207) Suggests It's 39% Undervalued
Hualan Biological Vaccine Inc.'s (SZSE:301207) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Calculating The Intrinsic Value Of Hualan Biological Bacterin Inc. (SZSE:301207)
Is It Smart To Buy Hualan Biological Bacterin Inc. (SZSE:301207) Before It Goes Ex-Dividend?
Express News | Hualan Biological Bacterin to Return to Profit in Q1
Declining Stock and Solid Fundamentals: Is The Market Wrong About Hualan Biological Bacterin Inc. (SZSE:301207)?
Hualan Biological Bacterin Gets Certification for Tetanus Vaccine
The Past One-year Earnings Decline for Hualan Biological Bacterin (SZSE:301207) Likely Explains Shareholders Long-term Losses
No Data